Bladder drug may unlock better blood flow for older women

NCT ID NCT07674680

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This early study tests whether a drug called gemtesa (used for overactive bladder) can improve blood vessel function in women aged 18 to 70. Researchers want to see if targeting beta3 receptors in blood vessels can help them relax and improve blood flow. The trial involves 60 healthy women and uses ultrasound to measure changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

gemtesa (vibegron)

What this could lead to

If beta3 receptors are found to help blood vessels work better, this could point toward new treatments for age-related heart issues in women.

What could go wrong

This is a very early, small study (60 people) testing a drug already approved for other uses. It may not show clear benefits or apply to all women.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Missouri

    Columbia, Missouri, 65211, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••